Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna Gets $750 Million in Flu Shot Funding, Stock Advances
01:26pm, Wednesday, 27'th Mar 2024
Moderna Inc. (MRNA) shares advanced Wednesday as the biotech firm used its “Vaccines Day” event to make key announcements about new funding and the results of several vaccine trials.
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
01:25pm, Wednesday, 27'th Mar 2024
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.
Moderna shares continue to fall even as its 3 vaccines enter final stage trials
10:19am, Wednesday, 27'th Mar 2024
Moderna Inc. saw its stock continue its downward trajectory on Wednesday morning, slipping by 1.2 percent to $106.21, following a decline of over 3 percent on Tuesday. The biotech company's shares hav
Moderna CEO on vaccines pipeline: Investing aggressively to bring important medicine to patients
08:30am, Wednesday, 27'th Mar 2024
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's annual vaccines day, the announcement of multiple vaccine programs advancing to late-stage clinical trials, Moderna's vaccines p
Moderna Gets $750 Million for Flu Program. Funding to Help Move Beyond Covid Vaccines.
08:12am, Wednesday, 27'th Mar 2024
The vaccine maker announces that Blackstone Life Sciences has agreed to fund up to $750 million for its flu program.
Moderna gets $750 mln funding from Blackstone Life Sciences to develop flu shots
06:52am, Wednesday, 27'th Mar 2024
Moderna said on Wednesday it has entered into an agreement with private equity firm Blackstone's life science investment platform for a funding of $750 million to develop its mRNA flu vaccines.
Moderna Says 'Next-Generation' COVID-19 Shot Had Positive Phase 3 Test Results
02:10pm, Tuesday, 26'th Mar 2024
Moderna Inc. (MRNA) on Tuesday reported "positive interim results" from a late-stage study of what it calls the "next-generation COVID-19 vaccine."
Moderna says new Covid vaccine showed stronger immune response than current shot in study
11:25am, Tuesday, 26'th Mar 2024
Moderna's new shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu.
Moderna Stock Pops as New Covid-19 Vaccine Shows Positive Results
08:13am, Tuesday, 26'th Mar 2024
Moderna's ‘next generation,' Covid-19 vaccine has shown a higher immune response to the virus than the current version of the shot.
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
03:46am, Saturday, 23'rd Mar 2024
The AI-in-healthcare market is expanding in the double digits and could reach more than $148 billion by the end of the decade. Nvidia CEO Jensen Huang says AI may have the most impact in the healthcar
Moderna (MRNA) Increases Yet Falls Behind Market: What Investors Need to Know
06:56pm, Monday, 18'th Mar 2024
Moderna (MRNA) concluded the recent trading session at $104.26, signifying a +0.39% move from its prior day's close.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
06:50am, Monday, 18'th Mar 2024
Wood added to one of her flagship fund's biggest holdings. The superstar investor also picked up shares of two other innovators that have posted double-digit share declines in recent years.
3 Precision Medicine Stocks That Could Benefit From the Industry's Rise
12:39pm, Friday, 15'th Mar 2024
Now might be a great time for investors to consider investing in precision medicine stocks. For those who don't know, precision medicine is an approach to disease treatment and prevention that tailors
This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery
09:15am, Friday, 15'th Mar 2024
Investing in biopharmaceutical stocks comes with more risks than some other types of stocks.
What's Next For Moderna Stock After Nearly A 20% Rise In A Week?
08:00am, Wednesday, 13'th Mar 2024
Moderna stock rallied 9% yesterday, after it launched phase 2/phase 3 clinical trials for a messenger RNA-based vaccine for skin cancer patients that it is developing with Merck. As per an earlier stu
